UnitedHealth drops Nexium
This article was originally published in The Tan Sheet
Astra-Zeneca's proton pump inhibitor Nexium (esomeprazole) was dropped from some UnitedHealth Group plans Sept. 1 and will be let go from others later this year, the firm says. The cost-sensitive measure reflects the lower-cost availability of Nexium predecessor Prilosec OTC (omeprazole), which AZ co-markets with Procter & Gamble. AZ is disappointed with the decision, saying it is not good for patients and overrides the better judgment of healthcare professionals, according to a spokesperson. The firm is not revising Nexium revenue projections. In recent years, other payors have chosen to remove Nexium and other PPIs from formularies, or to provide coverage for Prilosec OTC (1"The Tan Sheet" May 16, 2005, p. 11)...
You may also be interested in...
The Defense Department's decision to cease pharmacy benefit coverage of AstraZeneca's Nexium could pave the way for similar cost-cutting measures in other federal employee health plans
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.